3-D physiomimetic extracellular matrix hydrogels provide a supportive microenvironment for rodent and human islet culture.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
04 2019
Historique:
received: 05 04 2018
revised: 31 07 2018
accepted: 27 08 2018
pubmed: 19 9 2018
medline: 1 7 2020
entrez: 19 9 2018
Statut: ppublish

Résumé

Organ-on-a-chip platforms serve as cost-efficient testbeds for screening pharmaceutical agents, mimicking natural physiology, and studying disease. In the field of diabetes, the development of an islet-on-a-chip platform would have broad implications in understanding disease pathology and discovering potential therapies. Islet microphysiological systems are limited, however, by their poor cell survival and function in culture. A key factor that has been implicated in this decline is the disruption of islet-matrix interactions following isolation. Herein, we sought to recapitulate the in vivo peri-islet niche using decellularized extracellular matrix (ECM) hydrogels. Sourcing from porcine bladder, lung, and pancreas tissues, 3-D ECM hydrogels were generated, characterized, and validated using both rodent and human pancreatic islets. Optimized decellularization protocols resulted in hydrogels with distinctive viscoelastic properties that correlated to their matrix composition. The in situ 3-D encapsulation of human or rat islets within ECM hydrogels resulted in improved functional stability over standard culture conditions. Islet composition and morphology were also altered, with enhanced retention of islet-resident endothelial cells and the formation of cord-like structures or sprouts emerging from the islet spheroid. These supportive 3-D physiomimetic ECM hydrogels can be leveraged within microfluidic platforms for the long-term culture of islets.

Identifiants

pubmed: 30224090
pii: S0142-9612(18)30617-3
doi: 10.1016/j.biomaterials.2018.08.057
pmc: PMC6397100
mid: NIHMS1506842
pii:
doi:

Substances chimiques

Hydrogels 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-48

Subventions

Organisme : NIDDK NIH HHS
ID : U24 DK098085
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK098085
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK104208
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Références

Matrix Biol. 2008 Oct;27(8):667-73
pubmed: 18773957
Int J Mol Sci. 2017 Nov 29;18(12):
pubmed: 29186034
Adv Drug Deliv Rev. 2016 Jan 15;96:225-33
pubmed: 26212156
Cell Transplant. 2009;18(1):1-12
pubmed: 19476204
Biomaterials. 2013 Jul;34(22):5488-95
pubmed: 23583038
Sci Rep. 2017 Apr 12;7:45961
pubmed: 28401888
Biomaterials. 2013 Sep;34(28):6760-72
pubmed: 23787110
Exp Cell Res. 2002 Nov 1;280(2):179-91
pubmed: 12413884
Transplantation. 1998 Mar 15;65(5):722-7
pubmed: 9521209
Tissue Eng Part A. 2013 Dec;19(23-24):2544-52
pubmed: 23790218
J Biomed Mater Res B Appl Biomater. 2015 Feb;103(2):397-406
pubmed: 24895116
Tissue Eng Part B Rev. 2010 Aug;16(4):371-83
pubmed: 20121414
Transplantation. 2001 Jan 15;71(1):125-32
pubmed: 11211177
Adv Drug Deliv Rev. 2002 Jan 17;54(1):3-12
pubmed: 11755703
Science. 2010 Jul 30;329(5991):538-41
pubmed: 20576850
Acta Biomater. 2018 Feb;67:331-340
pubmed: 29191507
Lab Chip. 2013 Nov 21;13(22):4374-84
pubmed: 24056576
Development. 1995 Oct;121(10):3131-40
pubmed: 7588048
Transpl Immunol. 2004 Apr;12(3-4):367-77
pubmed: 15157928
J Virol. 2006 Jul;80(13):6218-24
pubmed: 16775309
Nat Mater. 2016 Jun;15(6):669-78
pubmed: 26950595
Transplantation. 2001 Dec 15;72(11):1730-6
pubmed: 11740381
Development. 1996 Feb;122(2):439-47
pubmed: 8625795
Vascul Pharmacol. 2014 Oct;63(1):19-28
pubmed: 24998908
Surgery. 1999 Aug;126(2):393-8
pubmed: 10455912
Transpl Int. 2009 Feb;22(2):207-16
pubmed: 18954375
J Cell Sci. 1993 Aug;105 ( Pt 4):1013-24
pubmed: 7693734
Cell Transplant. 2010;19(12):1523-35
pubmed: 20719076
Diabetes. 2006 Feb;55(2):312-7
pubmed: 16443762
Diabetologia. 1991 Feb;34(2):129-32
pubmed: 2065848
Adv Healthc Mater. 2018 Jan;7(2):
pubmed: 29283208
Semin Cell Dev Biol. 2002 Oct;13(5):377-83
pubmed: 12324220
Biomaterials. 2019 Apr;198:49-62
pubmed: 30007472
ACS Nano. 2017 Apr 25;11(4):3851-3859
pubmed: 28323411
Lab Chip. 2013 Sep 21;13(18):3538-47
pubmed: 23648632
Angiogenesis. 2008;11(3):223-34
pubmed: 18273688
J Biomater Sci Polym Ed. 2002;13(5):579-90
pubmed: 12182560
J Biomed Mater Res B Appl Biomater. 2008 Feb;84(2):408-14
pubmed: 17618508
Biochim Biophys Acta. 2015 Feb;1850(2):343-51
pubmed: 25445712
PLoS One. 2011;6(9):e24904
pubmed: 21961048
Lab Chip. 2009 Jan 7;9(1):97-106
pubmed: 19209341
Nat Med. 2008 Feb;14(2):213-21
pubmed: 18193059
Dev Cell. 2006 Mar;10(3):397-405
pubmed: 16516842
Clin Immunol. 2011 Feb;138(2):154-61
pubmed: 21094094
Sci Rep. 2018 Mar 2;8(1):3937
pubmed: 29500447
FASEB J. 2003 May;17(8):881-3
pubmed: 12670881
Biomaterials. 2009 Mar;30(8):1482-91
pubmed: 19121538
Diabetes. 2004 May;53(5):1318-25
pubmed: 15111502
J Histochem Cytochem. 1999 Apr;47(4):499-506
pubmed: 10082751
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7999-8004
pubmed: 10884429
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):749-758
pubmed: 28069397
Biomaterials. 2014 Oct;35(30):8585-95
pubmed: 25043571
Tissue Eng Part B Rev. 2011 Aug;17(4):235-47
pubmed: 21476869
Biochem Biophys Res Commun. 2003 Aug 29;308(3):474-9
pubmed: 12914774
Cell Transplant. 2013;22(7):1123-35
pubmed: 23031502
Cell Tissue Res. 1994 Jul;277(1):115-21
pubmed: 8055531
Diabetologia. 2009 Nov;52(11):2385-94
pubmed: 19669728
Diabetes. 1979 Dec;28(12):1108-13
pubmed: 389715
Diabetes. 2008 Sep;57(9):2393-401
pubmed: 18519803
Transpl Int. 1989 Apr;2(1):41-5
pubmed: 2504181
Biomed Microdevices. 2016 Oct;18(5):80
pubmed: 27534648
Lab Chip. 2015 Feb 7;15(3):823-32
pubmed: 25474044
Pancreas. 2000 Apr;20(3):270-6
pubmed: 10766453
J Proteome Res. 2017 Apr 7;16(4):1410-1424
pubmed: 28217993
Biomaterials. 2005 Apr;26(11):1211-8
pubmed: 15475050
J Control Release. 2017 Jul 10;257:91-101
pubmed: 27476611
Diabetologia. 2011 May;54(5):1127-35
pubmed: 21267536
J Am Coll Cardiol. 2012 Feb 21;59(8):751-63
pubmed: 22340268
J Biomed Mater Res A. 2014 Jan;102(1):234-46
pubmed: 23873846
Ann Biomed Eng. 2014 Jul;42(7):1517-27
pubmed: 24402648
Methods. 2015 Aug;84:25-34
pubmed: 25791470
J Immunol. 2011 Sep 1;187(5):2755-65
pubmed: 21813778
Diabetes. 1993 Oct;42(10):1514-9
pubmed: 8375592
Biomaterials. 2011 Feb;32(6):1536-42
pubmed: 21093908
Endocrinology. 2003 Dec;144(12):5149-58
pubmed: 12960095
Cell Transplant. 2006;15(6):489-97
pubmed: 17121160
Endocrinology. 2006 May;147(5):2315-24
pubmed: 16439446
Lab Invest. 1994 Aug;71(2):291-9
pubmed: 7521446
Biomaterials. 2011 Apr;32(12):3233-43
pubmed: 21296410
Acta Biomater. 2014 May;10(5):1806-16
pubmed: 24486910
Am J Physiol. 1997 Apr;272(4 Pt 1):E543-9
pubmed: 9142872
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10514-9
pubmed: 24982192
Cell Transplant. 2006;15(4):325-34
pubmed: 16898226
Physiol Rep. 2015 Dec;3(12):
pubmed: 26634904
Biomaterials. 2010 Mar;31(7):1676-82
pubmed: 20015544
Diabetes. 2002 Jan;51(1):55-65
pubmed: 11756323
Biomaterials. 2005 Dec;26(34):6811-7
pubmed: 16019062
Biomaterials. 2009 Oct;30(29):5409-16
pubmed: 19608268
Nat Commun. 2017 Apr 12;8:14923
pubmed: 28401884
Lab Chip. 2017 Feb 28;17(5):772-781
pubmed: 28157238
Diabetes. 2008 Nov;57(11):3045-55
pubmed: 18694973
Biomaterials. 2016 Jan;75:37-46
pubmed: 26476196
PLoS Genet. 2012;8(3):e1002552
pubmed: 22412385
J Biomed Mater Res A. 2007 Dec 1;83(3):626-35
pubmed: 17503531
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885

Auteurs

K Jiang (K)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

D Chaimov (D)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

S N Patel (SN)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

J-P Liang (JP)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

S C Wiggins (SC)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

M M Samojlik (MM)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States.

A Rubiano (A)

Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, United States.

C S Simmons (CS)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States; Department of Mechanical and Aerospace Engineering, University of Florida, Gainesville, FL, United States.

C L Stabler (CL)

J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, United States. Electronic address: cstabler@bme.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH